Your SlideShare is downloading. ×
0
Blake Lapthorn Professional Regulatory seminar 29 Jan 2013 with guest speaker Duncan Rudkin
Blake Lapthorn Professional Regulatory seminar 29 Jan 2013 with guest speaker Duncan Rudkin
Blake Lapthorn Professional Regulatory seminar 29 Jan 2013 with guest speaker Duncan Rudkin
Blake Lapthorn Professional Regulatory seminar 29 Jan 2013 with guest speaker Duncan Rudkin
Blake Lapthorn Professional Regulatory seminar 29 Jan 2013 with guest speaker Duncan Rudkin
Blake Lapthorn Professional Regulatory seminar 29 Jan 2013 with guest speaker Duncan Rudkin
Blake Lapthorn Professional Regulatory seminar 29 Jan 2013 with guest speaker Duncan Rudkin
Blake Lapthorn Professional Regulatory seminar 29 Jan 2013 with guest speaker Duncan Rudkin
Blake Lapthorn Professional Regulatory seminar 29 Jan 2013 with guest speaker Duncan Rudkin
Blake Lapthorn Professional Regulatory seminar 29 Jan 2013 with guest speaker Duncan Rudkin
Blake Lapthorn Professional Regulatory seminar 29 Jan 2013 with guest speaker Duncan Rudkin
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Blake Lapthorn Professional Regulatory seminar 29 Jan 2013 with guest speaker Duncan Rudkin

488

Published on

Blake Lapthorn were pleased to welcome Duncan Rudkin, Chief Executive and Registrar of the General Pharmaceutical Council as their speaker on 29 January 2013.

Blake Lapthorn were pleased to welcome Duncan Rudkin, Chief Executive and Registrar of the General Pharmaceutical Council as their speaker on 29 January 2013.

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
488
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Regulating people andsystems: a case studyDuncan RudkinChief Executive and RegistrarGeneral Pharmaceutical Council
  • 2. Who we are• Operational since 27 September 2010• Independent GB regulator for  – pharmacists,  – pharmacy technicians and  – pharmacies• Role to protect, promote and maintain the health, safety and  wellbeing of patients and people who use pharmacy services
  • 3. Who we are• We register competent professionals to practise pharmacy  and we regulate retail pharmacy services through the  registration of pharmacies• Our role as a professional and ‘system’ regulator is unique in  health professional regulation
  • 4. GPhC regulation
  • 5. What we do #1Professional regulation ‘System’ regulation• Register competent  • Register pharmacies professionals; check skills  • Inspect pharmacies to check  and knowledge up to date  mandatory standards are • Set and monitor  being met  professional standards   • In future, inspect against • Take action when our  new standards for  standards are not met, i.e.  registered pharmacies, with  Fitness to Practise new enforcement powers
  • 6. What we do #2Professional regulation ‘System’ regulation• Set education and training  • In future, use our  standards, accredit courses  enforcement powers to  and approve qualifications issue improvement notices, • Set and run the final  impose conditions and in  assessment for pharmacists  the most serious cases,  which they must pass to be  close pharmacies  eligible to register
  • 7. Professionalism• Prescriptive rules let us all off the hook• Professionalism, not rules and regulations, provides most  effective protection for patients and public• We are committed to regulating in a way which supports  pharmacy professionals to embrace and demonstrate  professionalism in their work• And working with pharmacy to encourage compliance with  our standards; enforcement a last resort• Positive focus on professionalism and accountability 
  • 8. Five key principles1. The governance arrangements safeguard the health, safety and wellbeing of patients and the  public2. Staff are empowered and competent to safeguard the health, safety and wellbeing of  patients and the public3. The environment and condition of the premises from which pharmacy services are provided,  and any associated premises, safeguard the health, safety and wellbeing of patients and the  public4. The way in which pharmacy services, including the management of medicines and medical  devices, are delivered safeguards the health, safety and wellbeing of patients and the public5. The equipment and facilities used in the provision of pharmacy services safeguard the health,  safety and wellbeing of patients and the public
  • 9. Issues• Corporate accountability vs. individual professional  accountability• The pharmacy superintendent• Blame vs. accountability• What the sub‐text says about attitudes to fitness to  practise• Implications for our approach to FtP• Risks for regulators
  • 10. For more information about our new standards, go to:http://www.pharmacyregulation.org/standards/standa rds‐registered‐pharmacies www.pharmacyregulation.org/
  • 11. Thank you

×